ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
BMPR1A | Bone morphogenetic protein receptor, type IA | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes
| | | | | Mixed |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK4 | Cyclin-dependent kinase 4 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CHEK2 | Checkpoint kinase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CYLD | Cylindromatosis (turban tumor syndrome) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
DICER1 | Dicer 1, ribonuclease type III | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERCC3 | Excision repair cross-complementing rodent repair deficiency, complementation group 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EXT1 | Exostosin glycosyltransferase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
EXT2 | Exostosin glycosyltransferase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
FANCA | Fanconi anemia, complementation group A | Cancer-related genes Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
FANCC | Fanconi anemia, complementation group C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FANCD2 | Fanconi anemia, complementation group D2 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
FANCE | Fanconi anemia, complementation group E | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
FANCF | Fanconi anemia, complementation group F | Cancer-related genes Disease related genes
| | | | | Mixed |
FANCG | Fanconi anemia, complementation group G | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
FLCN | Folliculin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
GPC3 | Glypican 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HRAS | Harvey rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
LMO1 | LIM domain only 1 (rhombotin 1) | Cancer-related genes Disease related genes
| | | | | Group enriched |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MEN1 | Multiple endocrine neoplasia I | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MLH1 | MutL homolog 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MPL | Myeloproliferative leukemia virus oncogene | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Not detected |
MSH2 | MutS homolog 2 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MSH6 | MutS homolog 6 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MUTYH | MutY homolog | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NBN | Nibrin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NF1 | Neurofibromin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
NF2 | Neurofibromin 2 (merlin) | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
PALB2 | Partner and localizer of BRCA2 | Cancer-related genes Disease related genes
| | | | | Expressed in all |